These genes are localised close to known cyclin-dependent kinase inhibitors and tumour suppressors CDKN1C and CDKN2A/B, respectively, but both FAF1 and MTAP have recently been proposed to harbour tumour suppressor activity in their own right. This evidence concerns the gene MTAP and neoplasm.